Rupreht J, Dworacek B
Anaesthesia Pharmacology Research School of Medicine, Erasmus University, Rotterdam, Netherlands.
Ann Fr Anesth Reanim. 1990;9(3):295-304. doi: 10.1016/s0750-7658(05)80190-x.
The central anticholinergic syndrome (CAS) includes central signs (somnolence, confusion, amnesia, agitation, hallucinations, dysarthria, ataxia, delirium, stupor, coma) and peripheral signs (dry mouth, dry skin, tachycardia, visual disturbances and difficulty in micturition). It occurs when central cholinergic sites are occupied by specific drugs and also as a result of an insufficient release of acetylcholine. The CAS can be caused by atropine sulphate, hyoscine (scopolamine), promethazine, benzodiazepines, opioids, halothane, influrane, ketamine. The incidence of CAS during the postoperative period depends on choice and dose of anaesthetic agents, type of surgery, patient's condition and diagnostic criteria. It is close to 10% following general anaesthesia and 4% following regional anaesthesia with sedation. The differential diagnosis of CAS includes an overdose of anaesthetic drugs or an alteration in pharmacokinetics, altered hydratation, electrolyte or acid-base state, hypoglycaemia, hypoxia, hypercapnia, hypocapnia, hyperthermia, hypothermia, hormonal disorders, neurological damage resulting from surgery, embolism, haemorrhage or trauma. The diagnosis of CAS is often determined by a process of exclusion and not actually made until a positive therapeutic response to physostigmine, a centrally active anticholinesterase agent has taken place.
中枢抗胆碱能综合征(CAS)包括中枢症状(嗜睡、意识模糊、失忆、激动、幻觉、构音障碍、共济失调、谵妄、昏迷、昏睡、昏迷)和外周症状(口干、皮肤干燥、心动过速、视觉障碍和排尿困难)。当特定药物占据中枢胆碱能位点时以及乙酰胆碱释放不足时都会发生这种情况。CAS可由硫酸阿托品、东莨菪碱、异丙嗪、苯二氮卓类、阿片类药物、氟烷、异氟烷、氯胺酮引起。术后CAS的发生率取决于麻醉剂的选择和剂量、手术类型、患者状况及诊断标准。全身麻醉后其发生率接近10%,区域麻醉加镇静后为4%。CAS的鉴别诊断包括麻醉药物过量或药代动力学改变、水合状态改变、电解质或酸碱状态改变、低血糖、低氧血症、高碳酸血症、低碳酸血症、体温过高、体温过低、激素紊乱、手术导致的神经损伤、栓塞、出血或创伤。CAS的诊断通常通过排除过程来确定,直到对中枢活性抗胆碱酯酶药物毒扁豆碱出现阳性治疗反应才实际做出诊断。